We evaluated how Bacillus coagulans Unique IS2 impacts functional constipation by conducting a double-blind, placebo-controlled study with 100 adults. Participants received either the probiotic or a placebo daily for four weeks.
By the end of the study, those taking the probiotic reported a significant increase in bowel movements and improved stool consistency. In fact, 98% of probiotic users achieved normal stool consistency, compared to just 74% in the placebo group.
Moreover, the probiotic group experienced relief from associated symptoms like painful defecation and abdominal pain. This shows Bacillus coagulans Unique IS2 is effective in treating constipation.
Read More
We investigated the effects of BIOVITA 3, a blend of three probiotic bacteria, on constipation in Sprague-Dawley rats. Using loperamide to induce constipation, we observed that those given BIOVITA 3 showed significant improvements in fecal volume, moisture, and gastrointestinal transit time. Additionally, we noted positive changes in gut health markers, including short chain fatty acids and microbial diversity. This promising research indicates that BIOVITA 3 could be a beneficial ingredient in foods aimed at relieving constipation.
Read More
We investigated how Bacillus subtilis can help with constipation by treating mice with this specific bacteria. Over one week, the mice that received B. subtilis showed improved colonic motility and higher levels of tryptophan, a precursor for serotonin, compared to those that did not receive the treatment.
Notably, these effects were linked to enhanced serotonin signaling, as blocking serotonin receptors hindered this benefit. However, heat-inactivated bacteria or a different strain lacking tryptophan synthesis did not produce similar outcomes, indicating that live, active bacteria are crucial for this effect.
Read More
We sought to understand how Bacillus subtilis affects slow transit constipation (STC) and its underlying mechanics. Using a mouse model, we treated STC with Bacillus subtilis and observed notable improvements.
Our findings showed that Bacillus subtilis significantly increased defecation rates and improved colon health. It also stimulated the release of serotonin from intestinal cells via the bile acid TGR5 receptor pathway, enhancing intestinal activity. Overall, this treatment appears beneficial for managing STC.
Read More
We investigated how the probiotic Bacillus Coagulans (BC01) affects constipation in a mouse model. Mice were divided into groups receiving either saline, the constipation-inducing agent loperamide, a control laxative, or BC01 at low and high doses.
After treatment, BC01 significantly improved intestinal movement and increased fecal water content, helping relieve constipation symptoms. It also positively influenced gut motility and overall health by restoring intestinal microbiota balance and regulating related gene expression.
Notably, the high-dose BC01 treatment showed the greatest effectiveness.
Read More